These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38349968)

  • 21. A negatively charged transmembrane aspartate residue controls activation of the relaxin-3 receptor RXFP3.
    Liu Y; Zhang L; Shao XX; Hu MJ; Liu YL; Xu ZG; Guo ZY
    Arch Biochem Biophys; 2016 Aug; 604():113-20. PubMed ID: 27353281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.
    Halls ML; Bathgate RA; Sutton SW; Dschietzig TB; Summers RJ
    Pharmacol Rev; 2015; 67(2):389-440. PubMed ID: 25761609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The electrostatic interactions of relaxin-3 with receptor RXFP4 and the influence of its B-chain C-terminal conformation.
    Wang XY; Guo YQ; Zhang WJ; Shao XX; Liu YL; Xu ZG; Guo ZY
    FEBS J; 2014 Jul; 281(13):2927-36. PubMed ID: 24802387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C-terminus of the B-chain of relaxin-3 is important for receptor activity.
    Shabanpoor F; Bathgate RA; Wade JD; Hossain MA
    PLoS One; 2013; 8(12):e82567. PubMed ID: 24349312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minimization of human relaxin-3 leading to high-affinity analogues with increased selectivity for relaxin-family peptide 3 receptor (RXFP3) over RXFP1.
    Shabanpoor F; Akhter Hossain M; Ryan PJ; Belgi A; Layfield S; Kocan M; Zhang S; Samuel CS; Gundlach AL; Bathgate RA; Separovic F; Wade JD
    J Med Chem; 2012 Feb; 55(4):1671-81. PubMed ID: 22257012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Addition of a carboxy-terminal green fluorescent protein does not alter the binding and signaling properties of relaxin family Peptide receptor 3.
    van der Westhuizen ET; Wade JD; Sexton PM; Summers RJ
    Ann N Y Acad Sci; 2009 Apr; 1160():105-7. PubMed ID: 19416168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Central injection of relaxin-3 receptor (RXFP3) antagonist peptides reduces motivated food seeking and consumption in C57BL/6J mice.
    Smith CM; Chua BE; Zhang C; Walker AW; Haidar M; Hawkes D; Shabanpoor F; Hossain MA; Wade JD; Rosengren KJ; Gundlach AL
    Behav Brain Res; 2014 Jul; 268():117-26. PubMed ID: 24681162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring electrostatic interactions of relaxin family peptide receptor 3 and 4 with ligands using a NanoBiT-based binding assay.
    Wang JH; Nie WH; Shao XX; Li HZ; Hu MJ; Liu YL; Xu ZG; Guo ZY
    Biochim Biophys Acta Biomembr; 2019 Apr; 1861(4):776-786. PubMed ID: 30684458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RLN3/RXFP3 Signaling in the PVN Inhibits Magnocellular Neurons via M-like Current Activation and Contributes to Binge Eating Behavior.
    Kania A; Szlaga A; Sambak P; Gugula A; Blasiak E; Micioni Di Bonaventura MV; Hossain MA; Cifani C; Hess G; Gundlach AL; Blasiak A
    J Neurosci; 2020 Jul; 40(28):5362-5375. PubMed ID: 32532885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Site-specific DOTA/europium-labeling of recombinant human relaxin-3 for receptor-ligand interaction studies.
    Zhang WJ; Luo X; Liu YL; Shao XX; Wade JD; Bathgate RA; Guo ZY
    Amino Acids; 2012 Aug; 43(2):983-92. PubMed ID: 22187146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution, physiology and pharmacology of relaxin-3/RXFP3 systems in brain.
    Ma S; Smith CM; Blasiak A; Gundlach AL
    Br J Pharmacol; 2017 May; 174(10):1034-1048. PubMed ID: 27774604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of central relaxin-3 signalling in sodium (salt) appetite.
    Smith CM; Walker LL; Chua BE; McKinley MJ; Gundlach AL; Denton DA; Lawrence AJ
    Exp Physiol; 2015 Sep; 100(9):1064-72. PubMed ID: 26147879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological activation of RXFP3 is not orexigenic in C57BL/6J mice.
    Smith CM; Hosken IT; Downer NL; Chua BE; Hossain MA; Wade JD; Gundlach AL
    Ital J Anat Embryol; 2013; 118(1 Suppl):52-5. PubMed ID: 24640572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elucidation of relaxin-3 binding interactions in the extracellular loops of RXFP3.
    Bathgate RA; Oh MH; Ling WJ; Kaas Q; Hossain MA; Gooley PR; Rosengren KJ
    Front Endocrinol (Lausanne); 2013; 4():13. PubMed ID: 23440673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The A-chain of human relaxin family peptides has distinct roles in the binding and activation of the different relaxin family peptide receptors.
    Hossain MA; Rosengren KJ; Haugaard-Jönsson LM; Zhang S; Layfield S; Ferraro T; Daly NL; Tregear GW; Wade JD; Bathgate RA
    J Biol Chem; 2008 Jun; 283(25):17287-97. PubMed ID: 18434306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relaxin-3 receptor (Rxfp3) gene knockout mice display reduced running wheel activity: implications for role of relaxin-3/RXFP3 signalling in sustained arousal.
    Hosken IT; Sutton SW; Smith CM; Gundlach AL
    Behav Brain Res; 2015 Feb; 278():167-75. PubMed ID: 25257104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure and activity in the relaxin family of peptides.
    Tregear GW; Bathgate RA; Hossain MA; Lin F; Zhang S; Shabanpoor F; Scott DJ; Ma S; Gundlach AL; Samuel CS; Wade JD
    Ann N Y Acad Sci; 2009 Apr; 1160():5-10. PubMed ID: 19416150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The structural and functional role of the B-chain C-terminal arginine in the relaxin-3 peptide antagonist, R3(BDelta23-27)R/I5.
    Hossain MA; Bathgate RA; Rosengren KJ; Shabanpoor F; Zhang S; Lin F; Tregear GW; Wade JD
    Chem Biol Drug Des; 2009 Jan; 73(1):46-52. PubMed ID: 19152634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel BRET-based binding assay for interaction studies of relaxin family peptide receptor 3 with its ligands.
    Wang JH; Shao XX; Hu MJ; Wei D; Liu YL; Xu ZG; Guo ZY
    Amino Acids; 2017 May; 49(5):895-903. PubMed ID: 28161795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of the domains in RXFP4 (GPCR142) responsible for the high affinity binding and agonistic activity of INSL5 at RXFP4 compared to RXFP3 (GPCR135).
    Zhu J; Kuei C; Sutton S; Kamme F; Yu J; Bonaventure P; Atack J; Lovenberg TW; Liu C
    Eur J Pharmacol; 2008 Aug; 590(1-3):43-52. PubMed ID: 18582868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.